Hubei Jumpcan Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -47.19% vs 93.24% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -47.08% vs 152.38% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,207.50",
          "val2": "2,286.60",
          "chgp": "-47.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "381.10",
          "val2": "913.40",
          "chgp": "-58.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.20",
          "val2": "2.00",
          "chgp": "210.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "19.30",
          "val2": "23.80",
          "chgp": "-18.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "399.10",
          "val2": "754.10",
          "chgp": "-47.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "315.60%",
          "val2": "365.80%",
          "chgp": "-5.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -22.46% vs -16.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -29.90% vs -10.27% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,141.60",
          "val2": "7,920.50",
          "chgp": "-22.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,164.80",
          "val2": "2,734.40",
          "chgp": "-20.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.30",
          "val2": "28.40",
          "chgp": "-56.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "41.30",
          "val2": "98.90",
          "chgp": "-58.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,778.30",
          "val2": "2,536.70",
          "chgp": "-29.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "301.80%",
          "val2": "306.30%",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,207.50

2,286.60

-47.19%

Operating Profit (PBDIT) excl Other Income

381.10

913.40

-58.28%

Interest

6.20

2.00

210.00%

Exceptional Items

19.30

23.80

-18.91%

Consolidate Net Profit

399.10

754.10

-47.08%

Operating Profit Margin (Excl OI)

315.60%

365.80%

-5.02%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -47.19% vs 93.24% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -47.08% vs 152.38% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,141.60

7,920.50

-22.46%

Operating Profit (PBDIT) excl Other Income

2,164.80

2,734.40

-20.83%

Interest

12.30

28.40

-56.69%

Exceptional Items

41.30

98.90

-58.24%

Consolidate Net Profit

1,778.30

2,536.70

-29.90%

Operating Profit Margin (Excl OI)

301.80%

306.30%

-0.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -22.46% vs -16.70% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -29.90% vs -10.27% in Dec 2024

All Annual Results